Monopar Therapeutics, Inc. (MNPR)
55.13
-0.26
(-0.47%)
USD |
NASDAQ |
Apr 02, 16:00
55.33
+0.20
(+0.36%)
After-Hours: 20:00
Monopar Therapeutics Total Liabilities (Quarterly) : 2.890M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Plus Therapeutics, Inc. | 12.33M |
| BioStem Technologies, Inc. | 10.89M |
| Iovance Biotherapeutics, Inc. | 214.59M |
| Protokinetix, Inc. | 0.2272M |
| GB Sciences, Inc. | 5.974M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 140.72M |
| Shareholders Equity (Quarterly) | 137.83M |
| Debt to Equity Ratio | 0.0011 |
| Current Ratio | 51.35 |
| Net Debt Paydown Yield | -0.01% |